Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Methyl group transfer pathways refer broadly to a set of interconnected biochemical cycles responsible for the transfer of methyl groups (–CH₃) to diverse substrates, including DNA, RNA, proteins (especially histones), and small molecules. These reactions are catalyzed primarily by *methyltransferases*, which use S-adenosylmethionine (SAM) as the universal methyl donor[1][2][3][4][5]. The methionine → SAM → S-adenosylhomocysteine (SAH) → homocysteine cycle is central to methyl group supply and recycling in cells, often termed the "SAM cycle" or one-carbon metabolism[1][3]. Methyl group transfer is crucial for epigenetic regulation, influencing gene expression, chromatin structure, and cellular differentiation[1][2][7]. Disruption of these pathways, whether by genetic variants or nutritional deficiencies (e.g., folate or vitamin B₁₂), has been linked to diseases such as cancer, neural tube defects, and neuropsychiatric conditions[3][7]. Because "methyl group transfer pathway" refers to a collection of processes and not a specific molecule, enzyme, or druggable target, it is **not considered a therapeutic target** per se—although individual enzymes (like DNA methyltransferases or protein methyltransferases) within these pathways are well-established drug targets in oncology and epigenetics[2][4][7]. **Note:** "Methyl group transfer pathways" are not a single molecular target, but rather a functional class or set of metabolic/epigenetic processes. For structured data systems, one should identify specific methyltransferase enzymes or methylation targets (e.g., DNA methyltransferase 1, protein arginine methyltransferase 5, etc.) for drug targeting or biomarker purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methyl group transfer pathway.